Pulse Biosciences(PLSE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PLSE Pulse Biosciences

Trading 12-08 13:15:38 EST

13.65

+0.38

+2.86%

High13.88	Low13.20	Vol65.60K
Open13.32	D1 Closing13.27	Amplitude5.12%
Mkt Cap925.03M	Tradable Cap238.03M	Total Shares67.77M
T/O887.02K	T/O Rate0.38%	Tradable Shares17.44M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PLSE","market":"US","secType":"STK","nameCN":"Pulse Biosciences","latestPrice":13.65,"timestamp":1765217620286,"preClose":13.27,"halted":0,"volume":65604,"delay":0,"floatShares":17438312,"shares":67767578,"eps":-1.132858,"marketStatus":"Trading","change":0.38,"latestTime":"12-08 13:15:38 EST","open":13.32,"high":13.88,"low":13.2,"amount":887023.221084,"amplitude":0.051243,"askPrice":13.72,"askSize":2,"bidPrice":13.65,"bidSize":27,"shortable":3,"etf":0,"ttmEps":-1.132858,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1765227600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1463544000000,"exchange":"NASDAQ","adjPreClose":13.27,"preHourTrading":{"tag":"盘前","latestPrice":13.4,"preClose":13.27,"latestTime":"09:29 EST","volume":3,"amount":40.2,"timestamp":1765204199061},"postHourTrading":{"tag":"盘后","latestPrice":13.27,"preClose":13.27,"latestTime":"17:27 EST","volume":963,"amount":12779.05,"timestamp":1764973666401},"volumeRatio":0.798389,"impliedVol":0.5119,"impliedVolPercentile":0.5},"requestUrl":"/m/hq/s/PLSE","defaultTab":"news","newsList":[{"id":"2585126247","title":"BRIEF-Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2585126247","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585126247?lang=en_us&edition=fundamental","pubTime":"2025-11-22 05:42","pubTimestamp":1763761365,"startTime":"0","endTime":"0","summary":"BRIEF-Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)Pulse Biosciences Inc PLSE.O:PULSE BIOSCIENCES ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)Source text: ID:nBw78W5GhaFurther company coverage: PLSE.O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nTUA927WQL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PLSE"],"gpt_icon":0},{"id":"2585125271","title":"Pulse Biosciences Grants Stock Options to New Employees Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2585125271","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585125271?lang=en_us&edition=fundamental","pubTime":"2025-11-22 05:05","pubTimestamp":1763759115,"startTime":"0","endTime":"0","summary":"Pulse Biosciences Inc. has granted inducement stock options to three new employees, totaling 13,450 shares of company common stock. The options carry an exercise price of $13.58 per share, matching the closing price on November 18, 2025. The awards will vest over four years, with one quarter vesting annually, contingent on continued employment. These options are issued under the company's 2017 Inducement Equity Incentive Plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pulse Biosciences Inc. published the original content used to generate this news brief via Business Wire  on November 21, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nNDL89f0sC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLSE","BK4082"],"gpt_icon":0},{"id":"2583591951","title":"Pulse Biosciences Updates Investors on Product Advancements","url":"https://stock-news.laohu8.com/highlight/detail?id=2583591951","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583591951?lang=en_us&edition=fundamental","pubTime":"2025-11-13 22:48","pubTimestamp":1763045317,"startTime":"0","endTime":"0","summary":"Pulse Biosciences ( ($PLSE) ) just unveiled an announcement. On November 13, 2025, Pulse Biosciences, Inc. released an updated investor presentatio...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pulse-biosciences-updates-investors-on-product-advancements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pulse-biosciences-updates-investors-on-product-advancements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLSE","ISBC","BK4211","BK4082"],"gpt_icon":0},{"id":"2581103410","title":"Pulse Biosciences Inc. to Present at Stifel 2025 Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2581103410","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581103410?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:08","pubTimestamp":1762463338,"startTime":"0","endTime":"0","summary":"Pulse Biosciences Inc. will participate in the Stifel 2025 Healthcare Conference in New York on November 13, 2025, where management is scheduled to present. The company leverages its nPulse technology using proprietary Nanosecond Pulsed Field Ablation energy.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pulse Biosciences Inc. published the original content used to generate this news brief via Business Wire  on November 06, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL20b8hr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3C00.GBP","IE00BQXX3F31.USD","LU0345774631.USD","LU1548497426.USD","LU1791710400.SGD","SGXZ81514606.USD","LU0267386448.USD","LU1043141396.HKD","LU2491050154.USD","LU2271345857.HKD","LU1571399168.USD","LU0823421333.USD","LU0211331839.USD","LU1116320901.HKD","IE00B19Z8X17.USD","LU0158827948.USD","LU1791710582.SGD","LU1815333072.USD","LU1815336760.USD","IE00BQXX3D17.EUR","PLSE","LU0187121727.USD","LU0994945656.USD","LU2491050071.SGD","LU1046421795.USD","LU0557290698.USD","LU1201861165.SGD","LU2087621335.USD","LU0203345920.USD","IE00B1XK9C88.USD","LU0477156797.USD","IE0004086264.USD","BK4612","LU1894683264.USD","LU0310800379.SGD","LU1066051498.USD","BK4077","LU1852331112.SGD","LU0094547139.USD","LU2242649171.HKD","LU0342679015.USD","LU0823421416.USD","LU2326559502.SGD","LU0942090050.USD","LU0466842654.USD","LU0130103400.USD","IE00BKDWB100.SGD","LU0477156953.USD","LU0225283273.USD"],"gpt_icon":1},{"id":"1113377153","title":"Pulse Biosciences FY2025 Q3 Earnings Call Summary and Q&A Highlights: Initial Revenue and Strategic Clinical Advancements","url":"https://stock-news.laohu8.com/highlight/detail?id=1113377153","media":"Earnings Call","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113377153?lang=en_us&edition=fundamental","pubTime":"2025-11-06 23:41","pubTimestamp":1762443668,"startTime":"0","endTime":"0","summary":"[Management View]Pulse Biosciences reported its first revenues from the nPulse platform and Vibrance disposables during a limited market release. Management emphasized the momentum in pilot and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLSE"],"gpt_icon":0},{"id":"2581181097","title":"Pulse Biosciences (PLSE) Earnings Transcript","url":"https://stock-news.laohu8.com/highlight/detail?id=2581181097","media":"Motley Fool Transcribing","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581181097?lang=en_us&edition=fundamental","pubTime":"2025-11-06 23:37","pubTimestamp":1762443447,"startTime":"0","endTime":"0","summary":"Image source: The Motley Fool.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_motley_transcript","url":"https://www.fool.com/earnings/call-transcripts/2025/11/06/pulse-biosciences-plse-earnings-transcript/","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/earnings/call-transcripts/2025/11/06/pulse-biosciences-plse-earnings-transcript/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_motley_transcript","symbols":["PLSE"],"gpt_icon":0},{"id":"2581094423","title":"Oppenheimer Keeps Their Buy Rating on Pulse Biosciences (PLSE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581094423","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581094423?lang=en_us&edition=fundamental","pubTime":"2025-11-06 22:29","pubTimestamp":1762439396,"startTime":"0","endTime":"0","summary":"Oppenheimer analyst Suraj Kalia maintained a Buy rating on Pulse Biosciences today and set a price target of $22.00. According to TipRanks, Kalia i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-keeps-their-buy-rating-on-pulse-biosciences-plse-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-keeps-their-buy-rating-on-pulse-biosciences-plse-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPY","PLSE"],"gpt_icon":0},{"id":"2581154702","title":"Pulse Biosciences Q3 EPS $(0.29) Beats $(0.31) Estimate, Sales $86.000K Miss $500.000K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2581154702","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581154702?lang=en_us&edition=fundamental","pubTime":"2025-11-06 05:26","pubTimestamp":1762378013,"startTime":"0","endTime":"0","summary":"Pulse Biosciences (NASDAQ:PLSE) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.31) by 6.45 percent. This is a 38.1 percent decrease over losses of $(0.21) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48670211/pulse-biosciences-q3-eps-0-29-beats-0-31-estimate-sales-86-000k-miss-500-000k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Pulse Biosciences Q3 EPS $(0.29) Beats $(0.31) Estimate, Sales $86.000K Miss $500.000K Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLSE"],"gpt_icon":0},{"id":"2581649702","title":"Pulse Biosciences Q3 Income From Operations USD -20.367 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581649702","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581649702?lang=en_us&edition=fundamental","pubTime":"2025-11-06 05:23","pubTimestamp":1762377803,"startTime":"0","endTime":"0","summary":"Nov 05 (Reuters) - Pulse Biosciences Q3 net income USD -19.385 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 05-NOV-202521:05:51.21 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nRSDSmbPW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PLSE"],"gpt_icon":0},{"id":"2581083183","title":"Pulse Biosciences Q3 EPS USD -0.29","url":"https://stock-news.laohu8.com/highlight/detail?id=2581083183","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581083183?lang=en_us&edition=fundamental","pubTime":"2025-11-06 05:05","pubTimestamp":1762376710,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nPLX5144AA:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLSE","BK4082"],"gpt_icon":0},{"id":"2580298182","title":"Pulse Biosciences Inc  expected to post a loss of 31 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2580298182","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580298182?lang=en_us&edition=fundamental","pubTime":"2025-11-04 06:07","pubTimestamp":1762207624,"startTime":"0","endTime":"0","summary":"Pulse Biosciences Inc  expected to post a loss of31cents a share - Earnings Preview Pulse Biosciences Inc PLSE.OQ PLSE.O is expected to  report resultson November 5 for the period ending September 30 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nL8N3WF2G8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLSE","BK4082"],"gpt_icon":0},{"id":"2578963489","title":"Pulse Biosciences Inc. Announces Date for Upcoming Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2578963489","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578963489?lang=en_us&edition=fundamental","pubTime":"2025-10-28 22:21","pubTimestamp":1761661260,"startTime":"0","endTime":"0","summary":"Pulse Biosciences Inc. has announced that its 2025 annual meeting of stockholders will be held on December 9, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pulse Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 28, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nNDL1NXP1m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLSE","BK4082"],"gpt_icon":0},{"id":"2577513364","title":"Pulse Biosciences enrolls first patient in NANOCLAMP AF study","url":"https://stock-news.laohu8.com/highlight/detail?id=2577513364","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577513364?lang=en_us&edition=fundamental","pubTime":"2025-10-24 19:37","pubTimestamp":1761305820,"startTime":"0","endTime":"0","summary":"Pulse Biosciences (PLSE) announced the enrollment of the first patient in its NANOCLAMP AF study for the treatment of atrial fibrillation. The succ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pulse-biosciences-enrolls-first-patient-in-nanoclamp-af-study-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pulse-biosciences-enrolls-first-patient-in-nanoclamp-af-study-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","PLSE"],"gpt_icon":0},{"id":"2577597747","title":"Pulse Biosciences Announces First Enrollment in the Nanoclamp Af Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2577597747","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577597747?lang=en_us&edition=fundamental","pubTime":"2025-10-24 19:00","pubTimestamp":1761303601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251024:nTUA11PL63:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","PLSE"],"gpt_icon":0},{"id":"2577023315","title":"Pulse Biosciences Inc. to Release Third Quarter 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2577023315","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577023315?lang=en_us&edition=fundamental","pubTime":"2025-10-23 04:05","pubTimestamp":1761163555,"startTime":"0","endTime":"0","summary":"Pulse Biosciences Inc. will report third quarter 2025 financial results and business updates on November 5, 2025, after market close. Results will be released on the Pulse Biosciences Investors website. Company management will host a conference call at 1:30pm PT / 4:30pm ET, and a live and recorded webcast will be available on the Pulse Biosciences Investors website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pulse Biosciences Inc. published the original content used to generate this news brief via Business Wire  on October 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251022:nNDL5nDPfc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PLSE"],"gpt_icon":0},{"id":"2576400164","title":"What Pulse Biosciences (PLSE)'s Positive Human Trial Data Could Mean for Its Cardiac Device Ambitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2576400164","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576400164?lang=en_us&edition=fundamental","pubTime":"2025-10-20 04:12","pubTimestamp":1760904730,"startTime":"0","endTime":"0","summary":"Pulse Biosciences, Inc. announced late-breaking results from its first-in-human feasibility study of the nPulse Cardiac Surgical System, presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting in Copenhagen, which showed high acute success rates and no major ablation-related adverse events in atrial fibrillation treatment.\nThe study highlighted not only strong early efficacy and safety, but also showcased the system's swift, efficient procedure workflow through...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-plse/pulse-biosciences/news/what-pulse-biosciences-plses-positive-human-trial-data-could","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-plse/pulse-biosciences/news/what-pulse-biosciences-plses-positive-human-trial-data-could","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4082","PLSE"],"gpt_icon":0},{"id":"2575583710","title":"Pulse Biosciences Grants Inducement Stock Options to New Employees Under 2017 Inducement Equity Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2575583710","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575583710?lang=en_us&edition=fundamental","pubTime":"2025-10-16 19:00","pubTimestamp":1760612433,"startTime":"0","endTime":"0","summary":"Pulse Biosciences Inc. has granted stock options to three new employees, allowing them to purchase a total of 8,550 shares of company common stock at an exercise price of $17.26 per share, matching the closing price on October 14, 2025. The options will vest over four years, with one-quarter of each award vesting annually, contingent on continued employment. These awards are issued under the company's 2017 Inducement Equity Incentive Plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pulse Biosciences Inc. published the original content used to generate this news brief via Business Wire  on October 16, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nNDL7Y8kcQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PLSE"],"gpt_icon":0},{"id":"2575671082","title":"Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2575671082","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575671082?lang=en_us&edition=fundamental","pubTime":"2025-10-16 19:00","pubTimestamp":1760612402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nTUA43LMV0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLSE","BK4082"],"gpt_icon":0},{"id":"2574174362","title":"Pulse Biosciences Reveals Promising Study Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2574174362","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574174362?lang=en_us&edition=fundamental","pubTime":"2025-10-10 21:28","pubTimestamp":1760102920,"startTime":"0","endTime":"0","summary":"Pulse Biosciences ( ($PLSE) ) has provided an announcement. On October 10, 2025, Pulse Biosciences announced the results of its first-in-human feas...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pulse-biosciences-reveals-promising-study-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pulse-biosciences-reveals-promising-study-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLSE","BK4082"],"gpt_icon":0},{"id":"2574120163","title":"Pulse Biosciences announces positive first in human trial results for nPulse Cardiac Surgical System in atrial fibrillation","url":"https://stock-news.laohu8.com/highlight/detail?id=2574120163","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574120163?lang=en_us&edition=fundamental","pubTime":"2025-10-10 19:00","pubTimestamp":1760094039,"startTime":"0","endTime":"0","summary":"Pulse Biosciences Inc. has announced late-breaking clinical study results from the first-in-human feasibility study of its nPulse Cardiac Surgical System, which utilizes proprietary Nanosecond Pulsed Field Ablation  technology for the treatment of atrial fibrillation. The results were presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting in Copenhagen, Denmark. The feasibility study aims to assess the initial safety and efficacy of the device, with 44 patients treated to date in Europe. In the initial cohort, electroanatomical mapping at approximately three months post-ablation showed a 94% pulmonary vein isolation  success rate per vein  and 100% acute success in posterior box isolation in the high-dose group. The average total ablation time was 50 seconds with an average of 13 applications. Pulse Biosciences plans to initiate an IDE study later this year to further validate the system.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nNDL97Gj0D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLSE","BK4082"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pulsebiosciences.com","stockEarnings":[{"period":"1week","weight":-0.0307},{"period":"1month","weight":-0.1844},{"period":"3month","weight":-0.1218},{"period":"6month","weight":-0.224},{"period":"1year","weight":-0.2926},{"period":"ytd","weight":-0.2378}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. The company was incorporated in 2014 and is headquartered in Hayward, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.042975},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.008676},{"month":3,"riseRate":0.333333,"avgChangeRate":0.004346},{"month":4,"riseRate":0.555556,"avgChangeRate":0.123266},{"month":5,"riseRate":0.333333,"avgChangeRate":0.00138},{"month":6,"riseRate":0.5,"avgChangeRate":0.006609},{"month":7,"riseRate":0.5,"avgChangeRate":0.013289},{"month":8,"riseRate":0.6,"avgChangeRate":0.001957},{"month":9,"riseRate":0.5,"avgChangeRate":0.125621},{"month":10,"riseRate":0.3,"avgChangeRate":0.008129},{"month":11,"riseRate":0.5,"avgChangeRate":0.107856},{"month":12,"riseRate":0.5,"avgChangeRate":0.084514}],"exchange":"NASDAQ","name":"Pulse Biosciences","nameEN":"Pulse Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pulse Biosciences(PLSE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pulse Biosciences(PLSE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pulse Biosciences,PLSE,Pulse Biosciences股票,Pulse Biosciences股票老虎,Pulse Biosciences股票老虎国际,Pulse Biosciences行情,Pulse Biosciences股票行情,Pulse Biosciences股价,Pulse Biosciences股市,Pulse Biosciences股票价格,Pulse Biosciences股票交易,Pulse Biosciences股票购买,Pulse Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pulse Biosciences(PLSE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pulse Biosciences(PLSE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction